Hindy J-R, Quintero-Martinez JA, Lee AT et al. Incidence Trends and Epidemiology of Staphylococcus aureus Bacteremia: A Systematic Review of Population-Based Studies. Cureus. 2022;14(5):e25460. https://doi.org/10.7759/cureus.25460

Gagliotti C, Högberg LD, Billström H, et al. Staphylococcus aureus bloodstream infections: diverging trends of meticillin-resistant and meticillin-susceptible isolates, EU/EEA, 2005 to 2018. Eurosurveillance. 2021;26(46):2002094. https://doi.org/10.2807/1560-7917.es.2021.26.46.2002094.

Renggli L, Gasser M, Buetti N, Kronenberg A. Resistance the SC for A. increase in methicillin-susceptible Staphylococcus aureus bloodstream infections in Switzerland: a nationwide surveillance study (2008–2021). Infection 2023;51(4):1025–31. https://doi.org/10.1007/s15010-023-01980-6

Kern WV. Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges. Curr Opin Infect Dis 2010;23(4):346–58. https://doi.org/10.1097/qco.0b013e32833bcc8a.

Austin ED, Sullivan SS, Macesic N, et al. Reduced mortality of Staphylococcus aureus Bacteremia in a Retrospective Cohort Study of 2139 patients: 2007–2015. Clin Infect Dis. 2020;70(8):1666–74. https://doi.org/10.1093/cid/ciz498.

Article  PubMed  Google Scholar 

López-Cortés LE, Toro MD, del, Gálvez-Acebal J, et al. Impact of an evidence-based bundle intervention in the quality-of-Care Management and Outcome of Staphylococcus aureus Bacteremia. Clin Infect Dis. 2013;57(9):1225–33. https://doi.org/10.1093/cid/cit499.

Article  PubMed  Google Scholar 

Fukushima S, Hagiya H, Kuninaga N, et al. Adherence to and clinical utility of quality indicators for Staphylococcus aureus bacteremia: a retrospective, multicenter study. Infection. 2024;52(4):1527–38. https://doi.org/10.1007/s15010-024-02284-z.

Article  PubMed  PubMed Central  Google Scholar 

Bai AD, Showler A, Burry L, et al. Impact of Infectious Disease Consultation on Quality of Care, Mortality, and length of stay in Staphylococcus aureus Bacteremia: results from a large Multicenter Cohort Study. Clin Infect Dis. 2015;60(10):1451–61. https://doi.org/10.1093/cid/civ120.

Article  PubMed  Google Scholar 

Loubet P, Burdet C, Vindrios W, et al. Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review. Clin Microbiol Infect. 2018;24(2):125–32. https://doi.org/10.1016/j.cmi.2017.07.003.

Article  PubMed  Google Scholar 

Li J, Echevarria KL, Traugott KA. β-Lactam Therapy for Methicillin‐Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins. Pharmacotherapy 2017;37(3):346–60. https://doi.org/10.1002/phar.1892

Davis J, Turnidge J, Tong S. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia. Int J Antimicrob Agents. 2018;52(2):297–300. https://doi.org/10.1016/j.ijantimicag.2018.02.013.

Article  PubMed  Google Scholar 

Lee S, Song K-H, Jung S-I, et al. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea. Clin Microbiol Infect. 2018;24(2):152–8. https://doi.org/10.1016/j.cmi.2017.07.001.

Article  PubMed  Google Scholar 

Miller WR, Seas C, Carvajal LP, et al. The Cefazolin Inoculum Effect is Associated with increased mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia. Open Forum Infect Dis. 2018;5(6):ofy123. https://doi.org/10.1093/ofid/ofy123.

Article  PubMed  PubMed Central  Google Scholar 

Westgeest AC, Buis DTP, Sigaloff KCE, et al. Global differences in the management of Staphylococcus aureus Bacteremia: No International Standard of Care. Clin Infect Dis. 2023;77(8):1092–101. https://doi.org/10.1093/cid/ciad363.

Article  PubMed  PubMed Central  Google Scholar 

Weis S, Kesselmeier M, Davis JS, et al. Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2019;25(7):818–27. https://doi.org/10.1016/j.cmi.2019.03.010.

Article  PubMed  Google Scholar 

Allen JM, Bakare L, Casapao AM, Klinker K, Childs-Kean LM, Pomputius AF. Cefazolin Versus Anti-staphylococcal Penicillins for the treatment of patients with methicillin-susceptible Staphylococcus aureus infection: a Meta-analysis with Trial Sequential Analysis. Infect Dis Ther. 2019;8(4):671–86. https://doi.org/10.1007/s40121-019-00259-4.

Article  PubMed  PubMed Central  Google Scholar 

Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, Sundararajan V. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–82. https://doi.org/10.1093/aje/kwq433.

Article  PubMed  Google Scholar 

Chang F-Y, Peacock JE, Musher DM, et al. Staphylococcus aureus Bacteremia Med. 2003;82(5):333–9. https://doi.org/10.1097/01.md.0000091184.93122.09.

Article  Google Scholar 

Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18–55. https://doi.org/10.1093/cid/ciq146.

Article  PubMed  Google Scholar 

Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45. https://doi.org/10.1086/599376.

Article  PubMed  Google Scholar 

Shapiro SM, Young E, De Guzman S, et al. Transesophageal echocardiography in diagnosis of infective endocarditis. Chest. 1994;105(2):377–82. https://doi.org/10.1378/chest.105.2.377.

Article  PubMed  Google Scholar 

Bai AD, Steinberg M, Showler A, et al. Diagnostic accuracy of transthoracic echocardiography for infective endocarditis findings using transesophageal echocardiography as the reference standard: a meta-analysis. J Am Soc Echocardiogr. 2017;30:639–e6468. https://doi.org/10.1016/j.echo.2017.03.007.

Article  PubMed  Google Scholar 

Cusumano JA, Dupper AC, Malik Y, et al. Staphylococcus aureus Bacteremia in patients infected with COVID-19: a Case Series. Open Forum Infect Dis. 2020;7(11):ofaa518. https://doi.org/10.1093/ofid/ofaa518.

Article  PubMed  PubMed Central  Google Scholar 

Adalbert JR, Varshney K, Tobin R, Pajaro R. Clinical outcomes in patients coinfected with COVID-19 and Staphylococcus aureus: a scoping review. BMC Infect Dis. 2021;21(1):985. https://doi.org/10.1186/s12879-021-06616-4.

Article  PubMed  PubMed Central  Google Scholar 

Fowler VG, Sanders LL, Sexton DJ, et al. Outcome of Staphylococcus aureus Bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis. 1998;27(3):478–86. https://doi.org/10.1086/514686.

Article  PubMed  Google Scholar 

Forsblom E, Ruotsalainen E, Ollgren J, Järvinen A. Telephone Consultation cannot replace Bedside Infectious Disease Consultation in the management of Staphylococcus aureus Bacteremia. Clin Infect Dis. 2013;56(4):527–35. https://doi.org/10.1093/cid/cis889.

Article  PubMed  Google Scholar 

Vogel M, Schmitz RPH, Hagel S, et al. Infectious disease consultation for Staphylococcus aureus bacteremia– a systematic review and meta-analysis. J Infect. 2016;72(1):19–28. https://doi.org/10.1016/j.jinf.2015.09.037.

Article  PubMed  Google Scholar 

Turner RB, Valcarlos E, Won R, Chang E, Schwartz J. Impact of infectious diseases Consultation on Clinical outcomes of patients with Staphylococcus aureus Bacteremia in a Community Health System. Antimicrob Agents Chemother. 2016;60(10):5682–7. https://doi.org/10.1128/aac.00439–16.

Oever Jten, Jansen JL, van der Vaart TW, Schouten JA, Hulscher MEJL, Verbon A. Development of quality indicators for the management of Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2019;74(11):3344–51. https://doi.org/10.1093/jac/dkz342.

Article  PubMed  PubMed Central  Google Scholar 

Thorlacius-Ussing L, Sandholdt H, Nissen J, et al. Comparable outcomes of short-course and prolonged-course therapy in selected cases of Methicillin-Susceptible Staphylococcus aureus Bacteremia: a pooled cohort study. Clin Infect Dis. 2021;73(5):866–72. https://doi.org/10.1093/cid/ciab201.

Article  PubMed  Google Scholar 

Minter DJ, Appa A, Chambers HF, Doernberg SB. Contemporary Management of Staphylococcus aureus Bacteremia—controversies in clinical practice. Clin Infect Dis. 2023;77(11):e57–68. https://doi.org/10.1093/cid/ciad500.

Article  PubMed  Google Scholar 

Thorlacius-Ussing L, Andersen CØ, Frimodt-Møller N, Knudsen IJD, Lundgren J, Benfield TL. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial. Trials. 2019;20(1):250. https://doi.org/10.1186/s13063-019-3357-9.

Article  PubMed  PubMed Central  Google Scholar 

Buis D, van Werkhoven C, van Agtmael M, et al. Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomized, controlled, open-label, noninferiority trial comparing 4 and 6 weeks of antibiotic treatment. BMJ Open. 2023;13(4):e068295. https://doi.org/10.1136/bmjopen-2022-068295.

Article  PubMed  PubMed Central  Google Scholar 

Mun SJ, Kim S-H, Huh K, et al. Role of echocardiography in uncomplicated Staphylococcus aureus catheter-related bloodstream infections. Medicine. 2021;100(18):e25679. https://doi.org/10.1097/md.0000000000025679.

Article